Published by IQ4I on 7th November 2017 | Ref: 1005267 | This Report Is In Stock
The drugs are classified as High Potent if its Occupational Exposure Limit (OELs) ≤ 10µg/m3.The HPAPI global market is progressively increasing in terms of revenue and the rise in demand for outsourcing these intermediates, manufacturing is driven by expansion of oncology sector, which is the fastest among overall pharmaceutical sector.
The global HPAPI market is valued to be $XX million in 2016 and poised to grow at a CAGR of X% to reach ,293.4 million by 2023. HPAPI market is mainly classified by customer base, by business type, by molecule type and Applications. The global HPAPI market is broadly classified as Innovative HPAPI and Generic HPAPI based on customer base. Based on business type, the market is classified into Captive HPAPI & Merchant HPAPI. HPAPI market is segmented on the basis of molecule type as Synthetic HPAPI and Biotech HPAPI. HPAPI market application segment is classified into Oncology, Cardiovascular, Central Nervous System, Hormonal, Glaucoma, Infectious, metabolic, Inflammation and other therapeutic applications.
Among Innovative & generic HPAPI, Innovative HPAPI occupies the major share in 2016 and generic HPAPIs expected to grow at a highest CAGR from 2016 to 2023. Among business type, Captive HPAPI occupies the major share of XX% in 2016 and Merchant HPAPI is expected to grow at a highest CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among molecule type, Synthetic HPAPI occupies the major share in 2016 and is expected to grow at a CAGR of X% from 2016 to 2023 to reach $XX million by 2023. Among Application segment, Oncology commanded the larger revenue of $XX million in 2016 and is expected to grow at a highest CAGR of X% from 2016 to 2023.
Increasing incidence of chronic and age related diseases, rapid growth in oncology market, growing demand for Antibody Drug Conjugates (ADC), technological advancements in HPAPI market, growing CMOs are some of the factors which are driving the market. Requirement of large investments, stringent safety and handling specifications associated with production of HPAPI, stringent regulations are the factors hindering the market.
North America accounts for the highest market share in 2016 and followed by Europe. However, Asian countries especially China and India are the fastest growing regions with its growing demand for HPAPIs. Asia-Pacific is projected to grow with a highest CAGR of XX% from 2016 to 2023.
Major players in HPAPI market include Alkermes plc (Ireland),Cambrex Corporation (U.S.),Dishman group (India), Dr. Reddy’s Laboratories (India), Lonza Group (Switzerland), Novasep (U.S.), Patheon N.V.( Netherland)(ThermoFisher Scientific), Pfizer (U.S.), Merck KGaA (Germany) and Teva Pharmaceutical Industries (Israel).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Rest of the World
1 EXECUTIVE SUMMARY 23
2 INTRODUCTION 28
2.1 KEY TAKE AWAYS 28
2.2 REPORT DESCRIPTION 29
2.3 MARKETS COVERED 30
2.4 STAKEHOLDERS 31
2.5 RESEARCH METHODOLOGY 32
3 MARKET ANALYSIS 42
3.1 INTRODUCTION 42
3.2 MARKET SEGMENTATION 43
3.3 FACTORS INFLUENCING MARKET 44
3.4 PORTER’S FIVE FORCE ANALYSIS 51
3.5 REGULATORY AFFAIRS 54
3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 59
3.7 SUPPLY CHAIN ANALYSIS 61
3.8 SELECTED TOP SELLING HPAPI 63
3.9 RECENT HPAPI INVESTMENTS 66
4 HPAPI GLOBAL MARKET, BY CUSTOMER BASE 72
4.1 INTRODUCTION 72
4.2 INNOVATIVE HPAPI 74
4.3 GENERIC HPAPI 75
5 HPAPI GLOBAL MARKET, BY BUSINESS TYPE 77
5.1 INTRODUCTION 77
5.2 CAPTIVE HPAPAI 78
5.3 MERCHANT HPAPI 80
6 HPAPI GLOBAL MARKET, BY MOLECULE TYPE 82
6.1 INTRODUCTION 82
6.2 SYNTHETIC HPAPIS 83
6.3 BIOTECH HPAPIS 85
7 HPAPI GLOBAL MARKET, BY APPLICATIONS 87
7.1 INTRODUCTION 87
7.2 CENTRAL NERVOUS SYSTEM DISORDERS 90
7.3 ONCOLOGY 92
7.4 HORMONAL DISORDERS 93
7.5 GLAUCOMA 95
7.6 INFECTIOUS DISEASES 96
7.7 METABOLIC DISORDERS 97
7.8 CARDIOVASCULAR 99
7.9 INFLAMMATION 100
7.10 OTHER THERAPEUTIC APPLICATIONS 101
8 REGIONAL MARKET ANALYSIS 103
8.1 INTRODUCTION 103
8.2 NORTH AMERICA 104
8.3 EUROPE 116
8.4 ASIA PACIFIC 135
8.5 REST OF THE WORLD (ROW) 152
9 COMPETITIVE LANDSCAPE 164
9.1 INTRODUCTION 164
10 . MAJOR COMPANIES 172
10.1 ALKERMES PLC 172
10.2 CAMBREX CORPORATION 179
10.3 DISHMAN GROUP 184
10.4 DR. REDDY’S LABORATORIES 188
10.5 LONZA GROUP 193
10.6 NOVASEP 199
10.7 PATHEON N.V.(THERMOFISHER SCIENTIFIC) 202
10.8 PFIZER INC. 209
10.9 MERCK KGAA 215
10.10 TEVA PHARMACEUTICAL INDUSTRIES 221
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Buy now using our secure payment system.